Achora Tetrabenazine 25mg in Pakistan | Tehran Chemie

Product Overview

Achora 25mg Tablet (Tetrabenazine) is a prescription neurological medicine manufactured by Tehran Chemie, Iran. It contains Tetrabenazine 25mg, a VMAT2 inhibitor that helps reduce involuntary movements, particularly chorea associated with Huntington’s disease. Achora 25mg should only be used according to the advice and supervision of a qualified healthcare professional.

If you are looking for information about Achora Tetrabenazine 25mg in Pakistan, ZarqTraders.com can provide product information and ordering assistance.

Product Details

• Product Name: Achora 25mg Tablet

• Active Ingredient: Tetrabenazine 25mg

• Manufacturer: Tehran Chemie

• Country of Origin: Iran

• Drug Class: VMAT2 inhibitor

• Dosage Form: Oral tablet

• Primary Medical Use: Chorea associated with Huntington’s disease

• Prescription: Use under medical supervision

• Availability: Pakistan

Key Points

• Contains Tetrabenazine 25mg.

• Manufactured by Tehran Chemie.

• Designed for management of involuntary movements associated with Huntington’s disease.

• Oral tablet formulation.

• Dose should be individualized by a doctor.

• Regular medical monitoring may be required during treatment.

• Do not start, stop, or change the dose without professional medical advice.

Benefits of Achora 25mg

Achora Tetrabenazine 25mg may help reduce chorea and involuntary movements in appropriately diagnosed patients. By inhibiting VMAT2, tetrabenazine reduces the storage and release of certain monoamines in nerve cells, helping decrease excessive involuntary movement. The principal therapeutic benefit is improved control of chorea rather than treatment of the underlying Huntington’s disease itself.

Potential benefits when prescribed appropriately include:

• Helps reduce involuntary movements.

• May improve control of chorea.

• Can support greater comfort during daily activities.

• May help patients maintain better motor control.

• Provides a recognized pharmacological option for Huntington’s-disease-associated chorea.

Dosage & Important Information

Tetrabenazine dosing must be individualized. Official prescribing information recommends gradual titration rather than automatically taking the full 25mg dose at once. A commonly described starting regimen is 12.5mg daily, followed after one week by 25mg daily divided into two 12.5mg doses, with further adjustments made by the physician according to response and tolerability.

Do not self-medicate with Achora 25mg. It is particularly important to discuss your medical history and all current medicines with your doctor before treatment.

Safety & Precautions

Tetrabenazine carries an important warning concerning depression and suicidal thoughts or behavior in patients with Huntington’s disease. Patients should be monitored for worsening depression, unusual behavioral changes, or suicidal thoughts. It is contraindicated in patients who are actively suicidal or have untreated/inadequately treated depression.

Other possible adverse effects include drowsiness or sedation, fatigue, insomnia, anxiety, nausea, and movement-related effects. Avoid driving or operating machinery if the medicine makes you sleepy or dizzy.

Buy Achora Tetrabenazine 25mg in Pakistan

For product information and availability, visit ZarqTraders.com and contact the seller for current stock and ordering details. Availability and prices can change, so confirm the current product, packaging, and prescription requirements before ordering.

ZarqTraders.com provides product information to help customers identify Achora Tetrabenazine 25mg and understand its general uses and precautions.

Important: This product description is for informational purposes and does not replace advice from a qualified doctor or pharmacist.